Kactus Biosystems
PrivateLast Round
Series B
Oct 20, 2022
Est. Valuation
$21.3M
Total Funding Raised
$55.31M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Kactus Biosystems is a biotechnology company that specializes in protein engineering and manufacturing, providing recombinant proteins, GMP-grade enzymes, and custom contract research services for drug discovery, immunotherapy, gene editing, and mRNA therapeutics.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Biotech Equipment
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Kactus Biosystems Comparables
Compare Kactus Biosystems with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BPS Bioscience | 85% | |
| ACROBiosystems | 82% | |
| ProSpec-Tany TechnoGene | 81% |
Kactus Biosystems Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Oct 20, 2022 | ||||
| Series A Extension | Jul 11, 2021 | ||||
| Series A | Sep 28, 2020 | ||||
| Pre Seed | Dec 20, 2018 | ||||
| Angel | Apr 26, 2018 | ||||
Angel | Mar 1, 2018 |
Key People
Founding team and executive leadership
Kactus Biosystems Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| New Alliance Capital | Series B |
| Lingang Blue Bay Capital | Series B |
| Shanghai Guofang Private Equity Fund Management | Series B |
| SDIC Venture Capital | Series A Extension, Series A |
| GF Capital Management & Advisors | Series B |
| Hudson Bay Capital Management | Series A Extension |
| Sherpa Healthcare Partners | Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors increased 68% MoM.
- May 22, 2026
Added Europabiosite, a biotechnology startup, as a customer.
Kactus Biosystems Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Kactus Biosystems's valuation, stock price, and market status.
Is Kactus Biosystems a public or private company?
Kactus Biosystems is a private company.
What is the current stock price of Kactus Biosystems?
Kactus Biosystems is a private company with no public stock price. No recent secondary market data is available.
How much is Kactus Biosystems worth (valuation)?
Kactus Biosystems's valuation is estimated at $21.3M based on funding round data.
Can I buy Kactus Biosystems stock?
Kactus Biosystems shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Kactus Biosystems's last funding round?
Kactus Biosystems's most recent funding round was Series B on September 28, 2020.
Who are the main investors in Kactus Biosystems?
Key investors in Kactus Biosystems include New Alliance Capital, Sherpa Healthcare Partners, Dehui Capital.
Will Kactus Biosystems IPO soon?
No public IPO plans have been announced for Kactus Biosystems.
How can I track Kactus Biosystems secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Kactus Biosystems's secondary market activity and sign up for updates.